Crucial Fact

  • Her favourite word was fact.

Last in Parliament November 2005, as Liberal MP for Edmonton Centre (Alberta)

Lost her last election, in 2006, with 39% of the vote.

Statements in the House

Health October 10th, 2002

Mr. Speaker, first let me say that I know that the hon. member has worked with his constituents in Nepean--Carleton around this important issue of primary health care reform.

I was pleased to be able to announce the $213 million contribution from our primary health care transition fund for the province of Ontario. These dollars are going to be used to expand community based primary health care reform, 24 hours a day, 7 days a week. In fact the Government of Ontario is working to expand this initiative across communities in the province.

I want to congratulate the hon. member because he and his constituents have--

Assisted Human Reproduction Act October 9th, 2002

moved for leave to introduce Bill C-13, an act respecting assisted human reproduction.

Mr. Speaker, this bill is in the same form as Bill C-56 from the first session of this Parliament and, in accordance with the special order of the House of October 7, 2002, I request that it be reinstated at the same stage that it had reached at the time of prorogation.

(Motions deemed adopted, bill read the first time and printed)

Pest Control Products Act October 9th, 2002

moved for leave to introduce Bill C-8, an act to protect human health and safety and the environment by regulating products used for the control of pests.

Mr. Speaker, this bill is in the same form as Bill C-53 from the first session of this Parliament. In accordance with the special order of the House of October 7, I request that it be reinstated at the same stage that it had reached at the time of prorogation.

(Motions deemed adopted, bill read the first time and printed)

Health October 8th, 2002

Mr. Speaker, we thank the Auditor General for her report today and her recommendations in relation to compliance activities around the Canada Health Act. In fact, as the Auditor General notes, a number of improvements have been made since the last report in 1999, including a dispute avoidance and resolution mechanism which the provinces, territories and federal government agreed to and which we all believe will enhance compliance activities under the CHA.

Health October 7th, 2002

Mr. Speaker, I have said on a number of occasions in the House that if in fact there is a violation of one of the five principles of the Canada Health Act we investigate those violations; we work with provincial officials. If we conclude that there is a violation that cannot be resolved, we have the power to withhold transfer payments.

The hon. member raises a very important question in and around the renewal of our health care system. Obviously we all await with great interest both Senator Kirby's and Commissioner Romanow's reports. Both will be coming in the coming months. I know that the hon. member will have much to say about the renewal of our health--

Committees of the House October 4th, 2002

Mr. Speaker, in accordance with Standing Order 109 I would like to present the government's response to the House of Commons Standing Committee on Agriculture and Agri-Food report entitled “Registration of Pesticides and the Competitiveness of Canadian Farmers”.

Health Care October 3rd, 2002

Mr. Speaker, we do in fact make inquiries. Whenever a concern is brought to our attention we monitor the situation very closely for possible violations of the Canada Health Act. We in fact work closely with provincial officials. We require information in many cases. I must say that the information is generally forthcoming. If there continue to be concerns that I may have in relation to the operation of a clinic, be it in relation to queue jumping or other things, we pursue that further and if necessary I take it up with my provincial counterpart to ensure that we are able to resolve the concern.

Health October 1st, 2002

Mr. Speaker, the hon. member should know that this government and this department are very much concerned with drug safety. That is why, as I have indicated, we have put additional resources toward post-marketing surveillance so that in fact we can deal with incidents of adverse reaction.

I think the hon. member is probably also aware that last week a very important report was released in relation to patient safety. Only one part of patient safety is, of course, adverse reactions to drugs. My provincial-territorial colleagues and I are very committed to taking up the recommendations in and around patient safety and obviously adverse reactions to drugs will be part of that.

Health October 1st, 2002

Mr. Speaker, as the hon. member probably is aware, some months ago we created the new marketed health products directorate at Health Canada. We have put additional resources into post-market surveillance to deal with the very issue that the hon. member has raised.

We are very concerned about adverse reactions in relation to drugs or other therapies and products. That is why we have enhanced our ability to do better and more timely surveillance to ensure the safety of the public.

Health June 21st, 2002

Mr. Speaker, I think it is fair to say that the government recognizes the importance to all Canadians in relation to the labelling of foods derived from biotechnology.

The hon. member has worked hard on this issue and is fully aware that the Standing Committee on Health is studying the matter. The Standing Committee on Agriculture and Agri-Food has just recently issued a report.

The hon. member is also aware that we have presently voluntary labelling of foods where biotechnology has been applied to those foods.

I want to reassure everyone while we await the report of the Standing Committee on Health, both the Department of Health and the Canadian Food Inspection Agency put the health and safety of Canadians first.